Batsche K, Ashby C R, Lee C, Schwartz J, Wang R Y
Department of Psychiatry, State University of New York at Stony Brook, New York.
J Pharmacol Exp Ther. 1994 Jun;269(3):1029-39.
In this study, we examined the effect of the isomers of the psychostimulant 2-amino-4-methyl-5-phenyl-delta 2-oxazoline (4-methylaminorex or 4-MAX) on behavior in rats. The s.c. administration of the stereoisomers of 4-MAX, trans-4S,5S, cis-4R,5S, cis-4S,5R and trans-4R,5R (0.3-3 mg/kg), produced a dose-dependent increase in locomotor activity. However, at a dose of 10 mg/kg, the isomers of 4-MAX produced an initial increase in locomotor activity followed by the appearance of stereotyped behaviors (continuous sniffing, chewing, head bobbing, etc.) then a subsequent phase of rebound-enhanced locomotor activity all over a time course of 4 hr. The rank order of potency for the stereoisomers of 4-MAX was: 4S,5S > 4R,5S =4S,5R < 4R,5R. To determine what neurotransmitter systems may mediate the action of 4-MAX, the ability of various receptor antagonists to block or attenuate the effect of trans-4S,5S-4-MAX (3 mg/kg s.c.) on locomotor activity was examined. The selective dopamine (DA) D1 antagonist (-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H- benzo- [d]naph-thio[2,1b]azepine (SCH 39166) and the D2 receptor antagonist (-)-eticlopride significantly, attenuated the behavioral action of trans-4S,5S-4-MAX, whereas antagonists to serotonergic and adrenergic receptors were ineffective. These results suggest that the ability of 4S,5S-4-MAX to induce locomotor hyperactivity and stereotypical behaviors and to increase rearing durations is primarily mediated by DA receptors. To determine whether the action of 4-MAX is dependent upon 5-hydroxytryptamine or DA concentrations in nerve terminals, rats were pretreated with either reserpine, alpha-methyl-p-tyrosine or d,l-p-chlorophenylalanine. Both reserpine and alpha-methyl-p-tyrosine pretreatment markedly attenuated the locomotor activity produced by trans-4S,5S-4-MAX. Moreover, L-dopa partially reversed the inhibitory action of alpha-methyl-p-tyrosine on 4S,5S-4-MAX-induced behavioral activation. In contrast, the administration of d,l-p-chlorophenylalanine did not alter the behavioral responses produced by trans-4S,5S-4-MAX. Taken together, our results suggest that 4-MAX may increase several locomotor behaviors by inducing neuronal DA release, which subsequently interacts with dopaminergic receptors.
在本研究中,我们检测了精神兴奋剂2-氨基-4-甲基-5-苯基-δ2-恶唑啉(4-甲基氨基苯丙胺或4-MAX)的异构体对大鼠行为的影响。皮下注射4-MAX的立体异构体反式-4S,5S、顺式-4R,5S、顺式-4S,5R和反式-4R,5R(0.3 - 3毫克/千克),可使运动活性呈剂量依赖性增加。然而,在剂量为10毫克/千克时,4-MAX的异构体最初会使运动活性增加,随后出现刻板行为(持续嗅探、咀嚼、点头等),然后在4小时的时间进程中出现运动活性反弹增强的后续阶段。4-MAX立体异构体的效价顺序为:4S,5S > 4R,5S = 4S, ,5R < 4R,5R。为了确定哪些神经递质系统可能介导4-MAX的作用,检测了各种受体拮抗剂阻断或减弱反式-4S,5S-4-MAX(3毫克/千克皮下注射)对运动活性影响的能力。选择性多巴胺(DA)D1拮抗剂(-)-反式-6,7,7a,8,9,13b-六氢-3-氯-2-羟基-N-甲基-5H-苯并[d]萘并[2,1b]氮杂卓(SCH 39166)和D2受体拮抗剂(-)-依托必利显著减弱了反式-4S,5S-4-MAX的行为作用,而5-羟色胺能和肾上腺素能受体拮抗剂则无效。这些结果表明,4S,5S-4-MAX诱导运动亢进和刻板行为以及增加竖毛持续时间的能力主要由DA受体介导。为了确定4-MAX的作用是否依赖于神经末梢中的5-羟色胺或DA浓度,用利血平、α-甲基-对-酪氨酸或d,l-对氯苯丙氨酸对大鼠进行预处理。利血平和α-甲基-对-酪氨酸预处理均显著减弱了反式-4S,5S-4-MAX产生的运动活性。此外,左旋多巴部分逆转了α-甲基-对-酪氨酸对4S,5S-4-MAX诱导的行为激活的抑制作用。相比之下,d,l-对氯苯丙氨酸的给药并未改变反式-4S,5S-4-MAX产生的行为反应。综上所述,我们的结果表明,4-MAX可能通过诱导神经元DA释放来增加多种运动行为,随后DA与多巴胺能受体相互作用。